TP53 and glioblastoma: The expression of CB1 and CB2 in human glioblastoma cell lines and tumor-derived cultures prompted us to investigate whether these cells would respond to cannabinoids and to what extent susceptibility to cannabinoids would be affected by TP53 and PTEN defects.